- Email: [email protected]
SOARD Category 1 CME Credit Featured Articles, Volume 13, March 2017
SOARD Category 1 CME Credit Featured Articles, Volume 13, March 2017 The utility of weight loss medications after bariatric surgery for weight regain or inadequate weight loss: A multi-center study Fatima Cody Stanford, Nasreen Alfaris, Gricelda Gomez, Elizabeth T. Ricks, Alpana P. Shukla, Kathleen E. Corey, Janey S. Pratt, Alfons Pomp, Francesco Rubino, Louis J. Aronne Surg Obes Relat Dis 2017;13;491-502
Objectives: After reading the featured articles published in this issue of Surgery for Obesity and Related Diseases (SOARD) participants in the SOARD CME program should be able to demonstrate increased understanding of the material specific to the article featured and be able to apply relevant information to clinical practice. Objectives are stated at the beginning of each featured article; the questions follow with three to five response choices, and a critique discussing the objective. Disclosure Statement: It is the policy of the American Society for Metabolic and Bariatric Surgery that speakers and/or anyone in control of content of a CME Category 1 event must disclose any financial or other relationship with (1) any manufacturer(s) of commercial products that may be discussed in the speaker’s presentation and/or (2) commercial supporters of the event. All disclosures are included under the list of author names. There was no commercial support received for this activity. Accreditation Statement: The American Society for Metabolic and Bariatric Surgery (ASMBS) is accredited
by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American Society for Metabolic and Bariatric Surgery (ASMBS) designates this educational activity for a maximum of 2 AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity. SOARD CME Online provides two articles from each issue for 2 credits per month; 1 credit per article. The article of month March on SOARD CME Online is: The utility of weight loss medications after bariatric surgery for weight regain or inadequate weight loss: A multi-center study Fatima Cody Stanford, Nasreen Alfaris, Gricelda Gomez, Elizabeth T. Ricks, Alpana P. Shukla, Kathleen E. Corey, Janey S. Pratt, Alfons Pomp, Francesco Rubino, Louis J. Aronne Surg Obes Relat Dis 2017;13;491-502
Continuing Medical Education Program / Surgery for Obesity and Related Diseases 13 (2017) 542–543
VOLUME 13
NUMBER 3
Learning objectives
Weight regain and inadequate weight loss is common after bariatric surgery. Weight loss medications may serve as an adjunct for persons with weight regain or inadequate weight loss. As monotherapy, topiramate appears to be the most effective drug for weight loss after bariatric surgery. Question 1 In the bariatric surgery population, significant weight regain (Z 15% gain of initial weight loss post bariatric surgery) occurs in what percentage of patients? A. B. C. D. E.
15-20% 20-25% 25-30% 25-35% 35-40%
Question 2 In our study, patients who were prescribed medicine for weight loss after bariatric surgery lost more weight if they are prescribed medications at: A. their weight plateau B. once weight regain had occurred
FEBRUARY 2017
Question 3 What was the percentage of additional weight loss conferred for patients on weight loss medications after bariatric surgery in our retrospective analysis? A. B. C. D. E.
3.4% 5.6% 7.6% 8.9% 10.1%
Question 4 Of the 15 medications prescribed by obesity medicine physicians within weight management centers, this medication and/or combination of medications appears statistically significant for weight loss after bariatric surgery. A. B. C. D. E.
Phentermine Topiramate Zonisamide Metformin Orlistat
543
Objectives: After reading the featured articles published in this issue of Surgery for Obesity and Related Diseases (SOARD) participants in the SOARD CME program should be able to demonstrate increased understanding of the material specific to the article featured and be able to apply relevant information to clinical practice. Objectives are stated at the beginning of each featured article; the questions follow with three to five response choices, and a critique discussing the objective. Disclosure Statement: It is the policy of the American Society for Metabolic and Bariatric Surgery that speakers and/or anyone in control of content of a CME Category 1 event must disclose any financial or other relationship with (1) any manufacturer(s) of commercial products that may be discussed in the speaker’s presentation and/or (2) commercial supporters of the event. All disclosures are included under the list of author names. There was no commercial support received for this activity. Accreditation Statement: The American Society for Metabolic and Bariatric Surgery (ASMBS) is accredited
by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American Society for Metabolic and Bariatric Surgery (ASMBS) designates this educational activity for a maximum of 2 AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity. SOARD CME Online provides two articles from each issue for 2 credits per month; 1 credit per article. The article of month March on SOARD CME Online is: The utility of weight loss medications after bariatric surgery for weight regain or inadequate weight loss: A multi-center study Fatima Cody Stanford, Nasreen Alfaris, Gricelda Gomez, Elizabeth T. Ricks, Alpana P. Shukla, Kathleen E. Corey, Janey S. Pratt, Alfons Pomp, Francesco Rubino, Louis J. Aronne Surg Obes Relat Dis 2017;13;491-502
Continuing Medical Education Program / Surgery for Obesity and Related Diseases 13 (2017) 542–543
VOLUME 13
NUMBER 3
Learning objectives
Weight regain and inadequate weight loss is common after bariatric surgery. Weight loss medications may serve as an adjunct for persons with weight regain or inadequate weight loss. As monotherapy, topiramate appears to be the most effective drug for weight loss after bariatric surgery. Question 1 In the bariatric surgery population, significant weight regain (Z 15% gain of initial weight loss post bariatric surgery) occurs in what percentage of patients? A. B. C. D. E.
15-20% 20-25% 25-30% 25-35% 35-40%
Question 2 In our study, patients who were prescribed medicine for weight loss after bariatric surgery lost more weight if they are prescribed medications at: A. their weight plateau B. once weight regain had occurred
FEBRUARY 2017
Question 3 What was the percentage of additional weight loss conferred for patients on weight loss medications after bariatric surgery in our retrospective analysis? A. B. C. D. E.
3.4% 5.6% 7.6% 8.9% 10.1%
Question 4 Of the 15 medications prescribed by obesity medicine physicians within weight management centers, this medication and/or combination of medications appears statistically significant for weight loss after bariatric surgery. A. B. C. D. E.
Phentermine Topiramate Zonisamide Metformin Orlistat
543